药物信息为QUIBRON -T (Theophylline Tablets USP) ACCUDOSE TabletsIMMEDIATE-RELEASE BRONCHODILATOR (Monarch Pharmaceuticals, Inc.): Description
- Description
- Clinical Studies
- Indications and Usage
- Contraindications
- Adverse Reactions
- How Supplied
- 外部链接相关的QUIBRON -T (Theophylline Tablets USP) ACCUDOSE TabletsIMMEDIATE-RELEASE BRONCHODILATOR (Monarch Pharmaceuticals, Inc.)
Theophylline is structurally classified as a methylxanthine. It occurs as a white, odorless, crystalline powder with a bitter taste. Anhydrous theophylline has the chemical name 1HPurine- 2,6-dione, 3,7-dihydro-1,3-dimethyl-, and is represented by the following structural formula:

The molecular formula of anhydrous theophylline is C7H8N4O2 with a molecular weight of 180.17.
Quibron®-T is available as tablets intended for oral administration, containing 300 mg of anhydrous theophylline per tablet. Quibron®-T is an oral bronchodilator in an immediate-release formulation in the ACCUDOSE® Tablet design. With functional trisects and bisects, Quibron®-T Tablets can be accurately divided into 100-, 150-, and 200-mg segments to provide a variety of dosing increments, as required.
QUIBRON®-T TABLETS 
One-third tablet = 100 mg One-half tablet = 150 mg Two-thirds tablet = 200 mg One tablet = 300 mg Inactive Ingredients: microcrystalline cellulose, yellow ferric oxide, hydroxypropyl methylcellulose 2910, lactose monohydrate, magnesium stearate, colloidal silicon dioxide, and sodium starch glycolate.
- Drug Information Provided by National Library of Medicine (NLM).
